针对HBP1/TIMP3轴作为一种针对乳腺癌的新策略
Yue Zhou1, Tongjia Zhang1, Shujie Wang1
1Department of Biochemistry and Biophysics, School of Basic Medical Sciences, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, Peking University Health Science Center, Beijing 100191, PR China.
Pharmacological research
|July 6, 2023
概括
高流动性组 (HMG) 盒含蛋白1 (HBP1) 和金属蛋白酶3 (TIMP3) 组织抑制剂轴抑制乳腺癌. 删除HBP1促进瘤生长和对治疗的抵抗力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌的死亡率主要是由恶性扩散和转移驱动的.
- 瘤抑制器高流动性组 (HMG) 盒含有蛋白1 (HBP1) 的蛋白在瘤中经常被删除或突变.
- 了解HBP1在乳腺癌中的作用对于开发向疗法至关重要.
研究的目的:
- 研究HBP1在抑制乳腺癌中的功能.
- 阐明HBP1瘤抑制活性背后的分子机制.
- 探索HBP1/TIMP3轴在乳腺癌治疗中的治疗影响.
主要方法:
- 分析HBP1对金属蛋白酶3 (TIMP3) 促进体活性的组织抑制剂的影响.
- 量化TIMP3,酸酶和张素同源 (PTEN) 和矩阵金属蛋白酶 (MMP2/9) 蛋白质和mRNA水平.
- 评估HBP1/TIMP3轴在乳腺癌进展和对治疗的反应中的作用.
主要成果:
- HBP1 增强了 TIMP3 促进剂活性,增加了 TIMP3 蛋白质和 mRNA 水平.
- TIMP3通过抑制其降解对PTEN进行上调,并对MMP2/9.9进行下调.
- 删除HBP1会破坏HBP1/TIMP3轴,促进乳腺癌的发生和进展.
结论:
- HBP1/TIMP3轴是乳腺癌瘤发生的关键抑制剂.
- 在乳腺癌中,HBP1删除有助于恶性进展和治疗耐药性.
- 针对HBP1/TIMP3轴提供了新的治疗策略,并改善了乳腺癌患者的预后.
关键词:
7,12-二甲基[a]甲烯 (DMBA,PubChem CID: 6001) 是一种甲基.乳腺癌是什么? 乳腺癌是什么酸二二甲酸盐 (PubChem CID: 61456) 的使用情况乙基甲基酸盐 (PubChem CID: 65064) 是一种乙烯基二胺四酸 (PubChem CID: 6049) 是一种在HBP1中,HBP1可能是HBP1.在MMP2/9/9上,我们可以看到MMP2/9/9的内容.在这里,我们可以看到PTEN.化 (PubChem CID:4873) 是一种化.二酸 (PubChem CID: 516951) 是一种酸.放射疗法是一种放射治疗.化 (PubChem CID: 5234) 是一种化物.二甲基硫酸盐 (PubChem CID: 3423265) 是一种硫酸盐.时间表3 TIMP3塔莫西芬 (PubChem CID: 2733526) 的使用情况甲胺 (PubChem CID: 6503) 的使用情况更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K